Status:

COMPLETED

The Effect of Upneeq (Oxymetazoline Hydrochloride 0.1%) on Eyelid Position, Eye Redness, and Eye Appearance

Lead Sponsor:

University of Miami

Conditions:

Ptosis, Eyelid

Conjunctiva Inflamed

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The purpose of the research is to see if Upneeq ( oxymetazoline 0.1% ophthalmic solution) has an effect on eyelid position, eye redness, or patient-perceived appearance of the eyes.

Eligibility Criteria

Inclusion

  • Adults age 18 and above able to provide informed consent to participate
  • Subject with stable ocular health, defined as no ocular conditions requiring ongoing topical therapy or recent surgical intervention

Exclusion

  • Adults unable to consent
  • Individuals less than 18 years of age
  • Prisoners
  • Pregnant women.
  • Known contradictions or sensitivities to study medication (oxymetazoline)
  • Ocular surgery within the past 3 months or refractive surgery within the past six months
  • Grossly abnormal lid margins, anatomical abnormalities, previous eyelid or orbital surgery
  • Variable ptosis or eyelid position (e.g., myasthenia gravis, thyroid eye disease, or blepharospasm)
  • Any ocular or systemic condition that, in the opinion of the investigator, would confound study data, interfere with the subject's study participation, or affected the subject's safety or trial parameters
  • Presence of an active ocular infection
  • Prior (within 5 days of beginning study treatment) use of eye whiteners (eg, vasoconstrictors), decongestants, antihistamines (including over the counter and herbal topical ophthalmic medications), phenylephrine dilating drops, any other topical ophthalmic agents
  • Inability to sit comfortably for 15 - 30 minutes

Key Trial Info

Start Date :

June 8 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2022

Estimated Enrollment :

114 Patients enrolled

Trial Details

Trial ID

NCT04831047

Start Date

June 8 2021

End Date

April 1 2022

Last Update

April 24 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Miami Bascom Palmer Eye Institute

Miami, Florida, United States, 33136